Sotera Health Co
NASDAQ:SHC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sotera Health Co
NASDAQ:SHC
|
US |
|
G
|
Grenergy Renovables SA
XMUN:5GR
|
ES |
|
XSpray Pharma AB (publ)
F:6XP
|
SE |
|
W
|
Wharf Holdings Ltd
OTC:WARFF
|
HK |
|
B
|
Bollore SE
XMUN:BOP
|
FR |
Wall St Price Targets
SHC Price Targets Summary
Sotera Health Co
According to Wall Street analysts, the average 1-year price target for SHC is 20.85 USD with a low forecast of 16.16 USD and a high forecast of 25.2 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SHC's stock price target?
Price Target
20.85
USD
According to Wall Street analysts, the average 1-year price target for SHC is 20.85 USD with a low forecast of 16.16 USD and a high forecast of 25.2 USD.
What is the Revenue forecast for Sotera Health Co?
Projected CAGR
7%
Over the last 6 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 7%.
What is the Gross Profit forecast for Sotera Health Co?
Projected CAGR
11%
Over the last 6 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 3 years is 11%.
What is the Operating Income forecast for Sotera Health Co?
Projected CAGR
19%
Over the last 6 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is 19%.
What is the Pre-Tax Income forecast for Sotera Health Co?
Projected CAGR
48%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 48%.
What is the Net Income forecast for Sotera Health Co?
Projected CAGR
64%
The compound annual growth rate for Net Income over the next 3 years is 64%.
